全文获取类型
收费全文 | 14533篇 |
免费 | 1178篇 |
国内免费 | 31篇 |
专业分类
耳鼻咽喉 | 170篇 |
儿科学 | 496篇 |
妇产科学 | 296篇 |
基础医学 | 2303篇 |
口腔科学 | 356篇 |
临床医学 | 1456篇 |
内科学 | 3080篇 |
皮肤病学 | 246篇 |
神经病学 | 1076篇 |
特种医学 | 513篇 |
外国民族医学 | 1篇 |
外科学 | 1997篇 |
综合类 | 133篇 |
一般理论 | 8篇 |
预防医学 | 1142篇 |
眼科学 | 333篇 |
药学 | 1158篇 |
1篇 | |
中国医学 | 14篇 |
肿瘤学 | 963篇 |
出版年
2022年 | 116篇 |
2021年 | 224篇 |
2020年 | 198篇 |
2019年 | 251篇 |
2018年 | 274篇 |
2017年 | 266篇 |
2016年 | 309篇 |
2015年 | 280篇 |
2014年 | 401篇 |
2013年 | 538篇 |
2012年 | 701篇 |
2011年 | 662篇 |
2010年 | 396篇 |
2009年 | 374篇 |
2008年 | 572篇 |
2007年 | 610篇 |
2006年 | 558篇 |
2005年 | 539篇 |
2004年 | 609篇 |
2003年 | 496篇 |
2002年 | 483篇 |
2001年 | 421篇 |
2000年 | 466篇 |
1999年 | 407篇 |
1998年 | 191篇 |
1997年 | 158篇 |
1996年 | 171篇 |
1995年 | 149篇 |
1994年 | 148篇 |
1993年 | 145篇 |
1992年 | 305篇 |
1991年 | 337篇 |
1990年 | 330篇 |
1989年 | 347篇 |
1988年 | 262篇 |
1987年 | 279篇 |
1986年 | 237篇 |
1985年 | 288篇 |
1984年 | 191篇 |
1983年 | 164篇 |
1982年 | 126篇 |
1981年 | 103篇 |
1980年 | 91篇 |
1979年 | 165篇 |
1978年 | 124篇 |
1977年 | 107篇 |
1975年 | 97篇 |
1974年 | 117篇 |
1973年 | 105篇 |
1972年 | 86篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
941.
Hansen SS Munk-Jørgensen P Guldbaek B Solgård T Lauszus KS Albrechtsen N Borg L Egander A Faurholdt K Gilberg A Gosden NP Lorenzen J Richelsen B Weischer K Bertelsen A 《Acta psychiatrica Scandinavica》2000,102(6):432-438
OBJECTIVE: To estimate the prevalence and possible under-diagnosing of substance use disorders and to consider factors that might influence diagnosing of substance use disorders. METHOD: Data collected from case records and PSE interviews of psychiatric in-patients from 12 psychiatric departments in Denmark admitted during October 1996 were compared with data from the Danish Psychiatric Register. RESULTS: A substantially lower prevalence of substance use diagnoses were found in the register (26.1%) than in the research data (50.0%). A high prevalence of co-occurrence between substance use disorders and mental disorders other than substance use disorders was found (37.3%). In the majority of cases knowledge of the substance use disorders was present in the case records, although they had not resulted in a diagnosis. CONCLUSION: The under-diagnosis of substance use disorders is due not only to concealed diagnostic signs and symptoms but also to an under-diagnosis by the psychiatrists, in spite of the fact that information on the substance use was accessible. 相似文献
942.
Buschard K Bock T Pedersen CR Hansen SV Aaen K Jørgensen M Hansen MW Kjaer TW Hageman I Josefsen K 《International journal of experimental diabetes research》2000,1(1):1-8
The aim of the study was to investigate whether various beta-cell stimulatory drugs, given neonatally, influence the incidence of diabetes in BB rats. Newborn BB rats were treated twice daily for 6 days and diabetes development was observed during the following 200-day study period. Compared to a diabetes incidence of 63.8% in 163 control BB rats which received saline or were untreated, the percentage of experimental BB rats that developed diabetes was as follows in the different subgroups: arginine-glucose: 47% (n = 73, p < 0.02); glucagon: 37% (n = 93, p < 0.0001); tolbutamide-glucose: 36% (n = 58, p < 0.0005); and theophylline-glucose: 39% (n = 41, p < 0.005). A long-term arginine-glucose treatment was not superior to the shorter neonatal treatment. Histological examination revealed a higher degree of insulitis in diabetic than in non-diabetic animals but no difference according to the kind of treatment was observed. Finally, we found that the diabetes incidence in BB rats was higher in the first litter compared to subsequent litters (p = 0.04). Thus, neonatal treatment with various beta-cell stimulatory agents reduces diabetes incidence in BB rats. The theory behind the study, that the treatment accelerates beta-cell maturation leading to increased immunological tolerance towards beta cells, is discussed. 相似文献
943.
Thomas Hansen Finn Egil Skjeldestad 《The European journal of contraception & reproductive health care》2007,12(4):303-308
Knowledge about oral contraceptives (OCs) was investigated among young users of OCs by profession of provider, namely, physician or public health nurse. A 44-item questionnaire designed to assess communication about contraception and knowledge of OCs was distributed to students in 11 of 13 high schools in Trondheim, Norway. Data from 688 OC users were eligible for analyses. Knowledge about OCs was measured by means of 15 questions, from which scores on three separate indices and a total index were determined. Separate indices included knowledge about physical changes during OC use (index I), knowledge about the pill's relative efficacy (index II) and knowledge about risks of cancer/ thromboembolism (index III). Logistic regression analyses showed that high scores with regard to knowledge indices were predicted by sexual activity and communication about contraception with peers and/or parents. Profession of provider was not associated with high knowledge scores. Information given during brief and annual discussions with health professionals appears to have an insignificant impact as compared with information from other sources. Our results plead for an over-the-counter practice. 相似文献
944.
Sajadieh A Wendelboe O Hansen JF Mortensen LS 《The American journal of cardiology》1999,83(8):1263-5, A9
The effect of nonsteroid anti-inflammatory drugs (NSAIDs) after acute myocardial infarction was studied in a retrospective study of 88 patients who were receiving regular NSAID treatment at randomization in the Danish Verapamil Infarction Trial II. There were no significant differences in mortality or major events between NSAID-treated patients versus controls (1,687); however, in a multivariate analysis a nonsignificant beneficial trend in favor of NSAIDs was observed. 相似文献
945.
The risk of cancer in users of verapamil was assessed in a long-term follow-up of 1,775 patients who were randomized to verapamil or matching placebo in the Danish Verapamil Infarction Trial-II in the years 1985 to 1987. During 10,474 patient-years, no increased risk of cancer was observed for the verapamil-treated men or women compared with the age- and sex-matched background population. 相似文献
946.
Calorie restriction in nonhuman primates: mechanisms of reduced morbidity and mortality 总被引:1,自引:0,他引:1
Long term chronic calorie restriction (CR) of adult nonhuman primates
significantly reduces morbidity and increases median age of death. The
present review is focused upon an ongoing study of sustained adult- onset
calorie restriction, which has been underway for 15 years. Monkeys,
initially calorie restricted at about 10 years of age, are now
approximately 25 years old. The median life span of these restricted
monkeys is increasing, now exceeding that of ad libitum (AL)-fed monkeys.
In our laboratory, maximum life span for AL-fed monkeys appears to be about
40 years. Thus, whether CR can also increase maximal life span, as it does
in rodents, cannot be determined for at least another 15 years. The
earliest detectable positive benefit on morbidity in these monkeys was
previously reported as the prevention of obesity. Current evidence, as
reviewed here, suggests that much obesity- associated morbidity is also
mitigated by sustained calorie restraint in nonhuman primates. Furthermore,
probably because of the prevention of obesity, diabetes has also been
prevented. Recent findings include the identification of extraordinary
changes in the glycogen synthesis pathway, and on the phosphorylation of
glycogen synthase in response to insulin. This calorie restriction-induced
prevention of morbidity does not require excessive leanness, but is clearly
present when body fat is within the normal range of 10 to 22%, and this is
likely to be true in humans as well.
相似文献
947.
Gammeltoft S Hansen BF Dideriksen L Lindholm A Schäffer L Trüb T Dayan A Kurtzhals P 《Expert opinion on investigational drugs》1999,8(9):1431-1442
In order to improve therapy and increase the quality of life for diabetic patients, it has been of significant interest to develop rapid-acting insulin preparations that mimic the physiological meal-time profile of insulin more closely than soluble human insulin. Insulin aspart (B28Asp human insulin) is a novel rapid-acting insulin analogue that fulfils this criterion. The B28Asp modification weakens the self-association of the insulin molecule and provides a more rapid absorption from the sc. injection site. The preclinical evaluation in vitro and in vivo demonstrates that apart from the more rapid absorption, insulin aspart is equivalent to human insulin. Thus, insulin aspart is equivalent to human insulin on key in vitro parameters such as insulin receptor affinity, insulin receptor dissociation rate, insulin receptor tyrosine kinase activation, IGF-I receptor binding affinity, metabolic and mitogenic potency. In accordance with the equivalent in vitro profiles, the toxico-pharmacological properties of insulin aspart and human insulin are also identical. The available data for insulin aspart and other rapid-acting insulin analogues supports that in vitro assays are sensitive and valuable in the preclinical evaluation of insulin analogues. Clinical studies demonstrate that insulin aspart has a pharmacokinetic and pharmacodynamic profile superior to that of soluble human insulin. In Type 1 diabetic patients on a basal-bolus injection regimen, insulin aspart given immediately before the meals provides an improved postprandial glycaemic control and an improved long-term metabolic control, as compared to soluble human insulin given 30 min before the meals, without increasing the risk of hypoglycaemia. Taken together, the data support the hope that insulin aspart will allow the diabetic patient to combine a more flexible lifestyle with better glycaemic control, without any increased safety risk. 相似文献
948.
Thalidomide has been shown to cause limb reduction defects in rabbits with much greater potency than in rats, possibly due to inherent biochemical differences between the two species. Whole embryo culture was used to make direct comparisons between thalidomide-sensitive New Zealand White rabbits and thalidomide-resistant Sprague-Dawley rats, focusing on the possible roles of glutathione (GSH) and cysteine in mechanisms of thalidomide teratogenicity. Conceptuses were treated by adding thalidomide (0, 5, 15, and 30 μM) directly to the culture media containing conceptuses of similar gestational stages. Embryos and visceral yolk sacs (VYS) were measured for changes in GSH and cysteine content using HPLC after 24 h of exposure in vitro. Thalidomide-induced (15 and 30 μM) depletion of VYS GSH occurred only in the rabbit, where GSH concentrations (pmol/μg protein) fell significantly to about 50% of control. Rat VYS did not show a significant GSH depletion at any thalidomide concentration tested. Comparison between species showed that the control rabbit VYS contained 35% less GSH than the control rat VYS. Control rat embryos and control rabbit embryos contained similar concentrations of GSH, but thalidomide treatment preferentially depleted GSH in the rabbit at lower thalidomide concentrations (5 μM). Cysteine concentrations were not significantly altered from control in the embryo or VYS of either species when treated with thalidomide. However, although control cysteine concentrations did not differ significantly between rat and rabbit VYS, control cysteine levels in rabbit embryos were 65% lower than those in control rat embryos. Rabbit conceptuses displayed lower species-specific GSH and cysteine levels and a greater propensity for thalidomide-induced GSH depletion than in rat conceptuses, consistent with the greater sensitivity of the rabbit to thalidomide teratogenicity. These thalidomide-induced and inherent species differences implicate a possible role for GSH and redox status in the mechanisms of thalidomide teratogenicity. 相似文献
949.
D F Smith A D Gee S B Hansen P Moldt E O Nielsen J Scheel-Krüger A Gjedde 《European neuropsychopharmacology》1999,9(4):351-359
This study tests the utility of a new selective serotonin reuptake inhibitor (SSRI), [11C]NS2381 {(+/-)-(8-[11C]methyl-3-(4-trifluoromethyl-phenyl)-8-azabicyclo[3.2.1]oc t-2-ene)}, as positron-emitting radioligand for labelling serotonin (5-HT) reuptake sites in living brain. Studies of monoamine uptake were carried out initially in vitro using rat brain synaptosomes. They showed that NS2381 and its precursor NS2435 are selective inhibitors of serotonin (5-HT) uptake. Then, studies were carried out in vivo on the uptake and distribution of [11C]NS2381 in living porcine brain. They showed that the radiotracer accumulates readily in brain, and binds reversibly in regions rich in serotonin uptake sites (e.g. raphe, basal ganglia and thalamus). In addition, [11C]NS2381 was displaced from brain tissue by the potent SSRI citalopram. The enantiomers of [11C]NS2381 were, in general, found to be similar to the racemate in terms of their uptake and distribution in living pig brain. Thus, [11C]NS2381 fulfilled several criteria of a PET radioligand for studying 5-HT uptake sites in the living brain. 相似文献
950.
Lassen UN Osterlind K Hirsch FR Bergman B Dombernowsky P Hansen HH 《British journal of cancer》1999,79(3-4):515-519
Based on an increased frequency of early death (death within the first treatment cycle) in our two latest randomized trials of combination chemotherapy in small-cell lung cancer (SCLC), we wanted to identify patients at risk of early non-toxic death (ENTD) and early toxic death (ETD). Data were stored in a database and logistic regression analyses were performed to identify predictive factors for early death. During the first cycle, 118 out of 937 patients (12.6%) died. In 38 patients (4%), the cause of death was sepsis. Significant risk factors were age, performance status (PS), lactate dehydrogenase (LDH) and treatment with epipodophyllotoxins and platinum in the first cycle (EP). Risk factors for ENTD were age, PS and LDH. Extensive stage had a hazard ratio of 1.9 (P = 0.07). Risk factors for ETD were EP, PS and LDH, whereas age and stage were not. For EP, the hazard ratio was as high as 6.7 (P = 0.0001). We introduced a simple prognostic algorithm including performance status, LDH and age. Using a prognostic algorithm to exclude poor-risk patients from trials, we could minimize early death, improve long-term survival and increase the survival differences between different regimens. We suggest that other groups evaluate our algorithm and exclude poor prognosis patients from trials of dose intensification. 相似文献